Xoma | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Ardelyx USD 173.29M 14.99M 2024-12
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Celldex Therapeutics USD 702.98M 44.02M 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Incyte USD 3.67B 219.94M 2025-03
Life Technologies USD 70.02M 4.69M 2024-12
MacroGenics USD 116.06M 4.01M 2024-12
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Prothena USD 486.93M 47.44M 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03



Xoma Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.